A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.

NCT00495365 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped This study was stopped due to slow enrollment

Conditions

Anemia
Chronic Renal Insufficiency

Interventions

DRUG: Epoetin alfa

Sponsor

Ortho Biotech Products, L.P.